Tag: non-small cell lung cancer

An investigational EGFR x HER3 antibody-drug conjugate showed promising efficacy and a manageable safety profile in previously treated EGFR-mutated lung ...

The prospective SARC-LUNG study links circulating immunometabolic biomarkers such as sRAGE and FGF21 with survival and immune microenvironment profiles in ...

A new study in Nature Communications is bringing fresh attention to one of the most consequential—and least visible—battlegrounds in non-small ...

In the relentless quest to overturn the biological complexities of cancer, a recent breakthrough sheds new light on the insidious ...

In the relentless battle against non-small cell lung cancer (NSCLC), one of the most formidable challenges faced by oncologists is ...

Emerging research from a leading group of scientists has shed new light on the complex interplay between systemic inflammation and ...

In recent years, the advent of immune checkpoint inhibitors (ICIs) has revolutionized cancer treatment paradigms, especially for patients diagnosed with ...

In a significant advancement in our understanding of lung carcinogenesis, a groundbreaking study recently published in Oncotarget unveils a critical ...

In a groundbreaking study published in the prestigious journal BMC Cancer, researchers have unveiled compelling evidence linking Cathepsin C (CTSC) ...

In the relentless quest to improve outcomes for non-small cell lung cancer (NSCLC) patients, a groundbreaking study has unveiled a ...